Theodora E. Markatseli

A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease

Dimitrios Daoussis, Ioannis Antonopoulos, Theodora E. Markatseli et al. · Seminars in Arthritis and Rheumatism · 2016 · 212 citations

Life Sciences, Immunology, Pharmacotherapy +14

Granuloma annulare induced by anti-tumour necrosis factor therapy

P.V. Voulgari, Theodora E. Markatseli, Sofia Exarchou et al. · Annals of the Rheumatic Diseases · 2007 · 103 citations

Medicine, Dermatology, Immunology +17

Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival

Irini Flouri, Theodora E. Markatseli, Paraskevi V. Voulgari et al. · Seminars in Arthritis and Rheumatism · 2013 · 95 citations

Medicine, Pharmacology, Pharmacotherapy +16

Cardiovascular risk profile in patients with spondyloarthritis

Charalampos Papagoras, Theodora E. Markatseli, Ioanna Saougou et al. · Joint Bone Spine · 2013 · 79 citations

Medicine, Clinical Sciences, Internal Medicine +10

Comparative Analysis and Predictors of 10-year Tumor Necrosis Factor Inhibitors Drug Survival in Patients with Spondyloarthritis: First-year Response Predicts Longterm Drug Persistence

Irini Flouri, Theodora E. Markatseli, Kyriaki Boki et al. · The Journal of Rheumatology · 2018 · 58 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14